TelyRx Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-10.06	-5.43	-13.48	-4.39
Depreciation & Amortization	0.29	0.33	0.09	0.03
Other Amortization	0.61	0.46	0.19	-
Loss (Gain) From Sale of Assets	0	0	-	-
Stock-Based Compensation	0.2	-	3.2	-
Other Operating Activities	1.8	0.6	9.59	3.71
Change in Accounts Receivable	-0.11	-0.08	-0.38	-0
Change in Inventory	-0.1	-0.89	-0.4	-0.06
Change in Accounts Payable	2.75	1.68	0.83	-0.23
Change in Other Net Operating Assets	2.41	2.56	0.16	-0.01
Operating Cash Flow	-2.22	-0.77	-2.86	-2.47
Capital Expenditures	-0.46	-0.59	-0.21	-0.04
Sale (Purchase) of Intangibles	-0.8	-0.86	-0.53	-0.32
Investment in Securities	-	-	-0.44	-
Other Investing Activities	0.83	-	-0.25	-
Investing Cash Flow	-0.44	-1.44	-1.43	-0.36
Long-Term Debt Issued	-	2	0.86	0.06
Long-Term Debt Repaid	-	-0.11	-0.18	-
Net Debt Issued (Repaid)	2.8	1.89	0.68	0.06
Issuance of Common Stock	23.83	-	6.55	0.29
Repurchase of Common Stock	-0	-0	-	-
Other Financing Activities	-	-	-0.06	-0.09
Financing Cash Flow	26.63	1.89	7.17	0.26
Net Cash Flow	23.97	-0.33	2.88	-2.57
Free Cash Flow	-2.68	-1.36	-3.07	-2.51
Free Cash Flow Margin	-4.84%	-3.16%	-32.17%	-9277.78%
Free Cash Flow Per Share	-0.25	-0.13	-0.40	-
Cash Interest Paid	1.08	0.11	0.05	-
Levered Free Cash Flow	-	-0.14	3.09	-
Unlevered Free Cash Flow	-	0.27	3.67	-
Change in Working Capital	4.94	3.27	0.21	-0.3